Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Cefoperazone Sodium and Sulbactam Sodium (1:1) Sterile API: A Cornerstone in Combating Bacterial Infections
In the relentless fight against bacterial pathogens, the availability of high-quality active pharmaceutical ingredients (APIs) is paramount. Among these, the combination of Cefoperazone Sodium and Sulbactam Sodium in a precise 1:1 ratio stands out as a powerful therapeutic agent. This synergistic blend is widely recognized for its efficacy against a broad spectrum of bacteria, including many strains that have developed resistance to other antibiotics. Understanding the properties, applications, and the critical importance of sourcing a sterile, high-purity form of this API is essential for pharmaceutical manufacturers dedicated to producing life-saving injectable medications.
The Synergistic Power: Cefoperazone and Sulbactam
Cefoperazone is a third-generation cephalosporin antibiotic. Its primary mechanism of action involves inhibiting the synthesis of bacterial cell walls, a process vital for bacterial survival. By binding to penicillin-binding proteins (PBPs) within the bacterial cell membrane, cefoperazone disrupts the cross-linking of peptidoglycans, leading to cell lysis and death. It is effective against a range of susceptible Gram-positive and Gram-negative organisms.
However, many bacteria have evolved mechanisms to resist beta-lactam antibiotics like cefoperazone. The most common mechanism is the production of beta-lactamase enzymes, which hydrolyze the beta-lactam ring of the antibiotic, rendering it inactive. This is where Sulbactam Sodium plays a crucial role. Sulbactam is a beta-lactamase inhibitor. While it has weak intrinsic antibacterial activity, its main function is to irreversibly bind to and inactivate various bacterial beta-lactamases. When combined with cefoperazone, sulbactam protects the cefoperazone molecule from enzymatic degradation, thereby extending its spectrum of activity and restoring its efficacy against beta-lactamase-producing resistant strains.
The 1:1 ratio of Cefoperazone Sodium to Sulbactam Sodium is specifically designed to optimize this synergistic effect, ensuring potent antibacterial activity against a wider range of challenging infections. This combination is particularly valuable in treating complex or severe infections where resistance is a concern.
Therapeutic Applications of the Combination API
The broad and enhanced spectrum of activity makes Cefoperazone Sodium and Sulbactam Sodium (1:1) API suitable for manufacturing finished drug products used to treat a variety of serious bacterial infections. These commonly include:
Its use is critical in hospital settings for managing infections where empirical therapy requires coverage against potential beta-lactamase producers.
The Imperative of Sterile API Manufacturing
Given that finished drug products containing Cefoperazone Sodium and Sulbactam Sodium (1:1) are predominantly administered parenterally (via injection), the use of a sterile API is not merely a preference but a fundamental requirement. A sterile API is manufactured under stringent controlled environmental conditions to ensure it is free from viable microorganisms. This is achieved through strict adherence to Good Manufacturing Practices (GMP), including operations within classified cleanrooms, environmental monitoring, and validated sterile processing techniques.
Beyond sterility, a high-quality API for injection must also have low levels of bacterial endotoxins, which are lipopolysaccharides released from the cell walls of Gram-negative bacteria. Endotoxins can cause pyrogenic (fever-inducing) reactions and other serious adverse effects when introduced into the bloodstream. Manufacturing a sterile API involves rigorous control measures and testing to minimize endotoxin levels, ensuring the safety of the final injectable product. The powder form of the API must maintain its integrity and sterility throughout the manufacturing process of the finished dosage form.
Adherence to Global Pharmacopoeial Standards
Quality is non-negotiable for pharmaceutical APIs. Cefoperazone Sodium and Sulbactam Sodium (1:1) API must conform to the monographs established by major global pharmacopoeias, such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), British Pharmacopoeia (BP), Japanese Pharmacopoeia (JP), and Chinese Pharmacopoeia (CP). Compliance with these standards ensures the API's identity, purity, potency, uniformity, and safety. Strict analytical testing is performed using validated methods to verify compliance with specifications for assay, impurities (including related substances and residual solvents), moisture content, particle size distribution (where relevant), and tests for sterility and endotoxins.
Sourcing an API that consistently meets or exceeds these stringent standards is crucial for drug product manufacturers seeking regulatory approval and ensuring patient safety and product efficacy worldwide. Reliable manufacturers invest heavily in quality control systems, analytical capabilities, and qualified personnel to guarantee batch-to-batch consistency and compliance.
Packaging and Storage for API Stability
The stability of Cefoperazone Sodium and Sulbactam Sodium (1:1) API is influenced by environmental factors such as moisture, light, and temperature. As a powder, it is typically supplied in packaging designed to protect it from degradation. Common packaging includes airtight and light-resistant containers, such as tins or drums, often within larger cartons for transport. Typical package sizes mentioned in the industry range from 10 KG to 15 KG tins, although customized packaging may be available depending on the manufacturer or supplier. Proper storage conditions require keeping the API in a cool place, away from direct light and excessive humidity, to maintain its quality and shelf life as specified by the manufacturer.
Regulatory Support and Documentation
Navigating the complex landscape of pharmaceutical regulation across different countries requires comprehensive documentation and support from the API manufacturer. A well-maintained Drug Master File (DMF) is a critical component. A DMF provides confidential, detailed information about the API manufacturing process, quality control, packaging, and stability data to regulatory agencies (like the FDA in the US or EMA in Europe). Availability of DMF and strong regulatory affairs support significantly streamlines the drug product registration process for the customer. Reliable API suppliers offer extensive regulatory assistance, including providing necessary documentation and answering questions from regulatory authorities.
Sourcing and Procurement: Finding a Reliable Supplier
For pharmaceutical companies, finding a reliable supplier of high-quality Cefoperazone Sodium and Sulbactam Sodium (1:1) Sterile API is a critical business decision. The chosen manufacturer or supplier must demonstrate a proven track record of producing sterile APIs under strict GMP conditions, consistently meeting pharmacopoeial standards, and providing robust regulatory support. Key considerations when looking to buy or purchase this API include the supplier's quality certifications, audit reports, stability data, and their capacity to meet supply demands reliably. While price is always a factor in procurement, it should never compromise quality or regulatory compliance. Comparing the total value proposition, including quality assurance, regulatory support, supply chain reliability, and competitive price, is essential. Minimum order quantities (MOQ), such as 1kg for initial sampling or smaller scale production, are often available, with larger quantities for commercial supply typically negotiated.
Conclusion
Cefoperazone Sodium and Sulbactam Sodium (1:1) Sterile API powder remains an indispensable tool in the clinical management of serious bacterial infections, particularly those involving resistant strains. Its efficacy relies not only on the inherent properties of the molecules but critically on the quality and sterility of the API itself. Sourcing this vital ingredient from a reputable manufacturer and supplier that adheres to the highest global quality standards, offers comprehensive regulatory support, and provides reliable supply is fundamental for pharmaceutical companies aiming to produce safe, effective, and compliant injectable drug products. The decision to purchase this API should prioritize quality and partnership over mere price, ensuring the integrity and effectiveness of the final medicine that reaches patients in need.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
